Screener
Organon OGN Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Organon in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Organon’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 8:46 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029532
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Contingencies (Note 15) | ||
| Organon & Co. Stockholders’ Equity: | ||
| Common stock, $0.01 par valueAuthorized - 500,000Issued and outstanding - 262,649 in 2026 and 260,316 in 2025 | 3 | 3 |
| Additional paid-in capital | 186 | 167 |
| Retained earnings | 1,253 | 1,109 |
| Accumulated other comprehensive loss | (539) | (527) |
| Total Stockholders’ Equity | 903 | 752 |
| Total Liabilities and Stockholders’ Equity | $12,996 | $12,867 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Organon's retained earnings?
- Organon (OGN) reported retained earnings of $1.25B in Q1 2026.
- How has Organon's retained earnings changed year-over-year?
- Organon's retained earnings increased by 22.1% year-over-year, from $1.03B to $1.25B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Organon's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude